LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹13 Cr | ₹11 Cr | ₹7.94 Cr | ₹6.46 Cr | ₹5.69 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹7.94 Cr |
| Mar2022 | ₹6.46 Cr |
| Mar2021 | ₹5.69 Cr |
How is Deferred Tax Assets / Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 13.50 | |
| Mar2024 | ₹11 Cr | 44.26 | |
| Mar2023 | ₹7.94 Cr | 23.02 | |
| Mar2022 | ₹6.46 Cr | 13.42 | |
| Mar2021 | ₹5.69 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,270.2 Cr | 3.5% | 37.6% | -7.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 3.5% |
37.6% |
-7.4% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses